BMJ · 1971 · 16 citations · 4 references
PharmacyPharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacodynamicsBlood Pressure ManagementHemodynamic PharmacologyHypertension ManagementHypertension PharmacotherapyAdverse Hemodynamic EffectsBlood Pressure PharmacodynamicsSide Effect ProfileSupine HypertensionSystolic Blood Pressure
In a titrated dose cross-over trial of debrisoquine and methyldopa in 38 hypertensive patients neither drug was superior in lowering supine or standing diastolic pressure with a minimum of side effects. Methyldopa caused significantly greater reduction of supine (P<0.001) and standing (P<0.02) systolic pressure but caused intolerable side effects in two patients. Tiredness was the most characteristic and troublesome side effect with methyldopa and postural hypotension was prominent in patients while on debrisoquine.
4
A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS
G Rose, W. W. Holland, Emma Crowley · The Lancet · 1964 · 332 citations
Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison
B. N. C. Prichard, Alan Johnston, Ivor D. Hill et al. · BMJ · 1968 · 109 citations · Full text
Hospital Infection, Causes and Prevention
Postgraduate Medical Journal · 1967 · 43 citations · Full text